McKesson Corp. said Monday it has reached an agreement to acquire Rx Savings Solutions for up to $875 million. Rx Savings Solutions is a prescription price transparency and benefit information company that serves about 17 million patients. The deal includes a $600 million upfront payment and up to $275 million in payments based on certain financial performance milestones through calendar year 2025. The deal is expected to close in the second half of fiscal 2023. “We expect the acquisition of Rx Savings Solutions to accelerate McKesson’s growth priority in biopharma services by extending our ecosystem of differentiated medication access solutions to patients,” said McKesson CEO Brian Tyler in a statement. Shares were down 0.8% premarket, but have gained 39% in the year to date, while the S&P 500 has fallen 19%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
0
0